Acute accumulation of PIM2 and NRF2 and recovery of β5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitors-Reference-Cited by-同舟云学术

Acute accumulation of PIM2 and NRF2 and recovery of β5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitors

Published:2024-01-21 Issue:3 Volume:119 Page:303-315
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Sogabe Kimiko,Nakamura Shingen^ORCID,Higa Yoshiki,Miki Hirokazu,Oda Asuka,Maruhashi Tomoko,Sumitani Ryohei,Oura Masahiro,Takahashi Mamiko,Nakamura Masafumi,Maeda Yusaku,Hara Tomoyo,Yamagami Hiroki,Fujii Shiro,Kagawa Kumiko,Ozaki Shuji,Kurahashi Kiyoe,Endo Itsuro,Aihara Ken-ichi,Nakaue Emiko,Hiasa Masahiro,Teramachi Jumpei,Harada Takeshi,Abe Masahiro

Funder

Japan Society for the Promotion of Science

the Research Clusters program of Tokushima University

Japanese Society of Hematology

Myeloma patients and families

Myeloma patietns and families

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12185-023-03705-9.pdf

Reference37 articles.

1. Asano J, Nakano A, Oda A, Amou H, Hiasa M, Takeuchi K, et al. The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells. Leukemia. 2011;25(7):1182–8. https://doi.org/10.1038/leu.2011.60.